These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7045666)

  • 1. The use of an implantable insulin pump in the treatment of type II diabetes.
    Rupp WM; Barbosa JJ; Blackshear PJ; McCarthy HB; Rohde TD; Goldenberg FJ; Rublein TG; Dorman FD; Buchwald H
    N Engl J Med; 1982 Jul; 307(5):265-70. PubMed ID: 7045666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of the insulin infusion pump in 100 patients with type I diabetes.
    Mecklenburg RS; Benson JW; Becker NM; Brazel PL; Fredlund PN; Metz RJ; Nielsen RL; Sannar CA; Steenrod WJ
    N Engl J Med; 1982 Aug; 307(9):513-8. PubMed ID: 7099222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive conventional and insulin pump therapies in adult type I diabetes. A crossover study.
    Nathan DM; Lou P; Avruch J
    Ann Intern Med; 1982 Jul; 97(1):31-6. PubMed ID: 7046554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study.
    Maiorino MI; Bellastella G; Casciano O; Cirillo P; Simeon V; Chiodini P; Petrizzo M; Gicchino M; Romano O; Caruso P; Giugliano D; Esposito K
    Diabetes Technol Ther; 2018 Feb; 20(2):117-126. PubMed ID: 29303370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels.
    Tamborlane WV; Hintz RL; Bergman M; Genel M; Felig P; Sherwin RS
    N Engl J Med; 1981 Aug; 305(6):303-7. PubMed ID: 7017416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems.
    Ziegler R; Tubili C; Chico A; Guerci B; Lundberg E; Borchert M; Löffler A; Bloethner S; Weissmann J; Pfützner A
    Diabetes Technol Ther; 2013 Sep; 15(9):738-43. PubMed ID: 23931739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of insulin pumps in the management of insulin dependent diabetes.
    Greene SA; Smith MA; Baum JD
    Arch Dis Child; 1983 Aug; 58(8):578-81. PubMed ID: 6351759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on control of glycemia with conventional insulin therapy or continuous subcutaneous insulin infusion.
    Tamborlane WV; Champion MC; Rizza RA; Service FJ; Bergenstal RM
    Diabetes; 1985 Aug; 34 Suppl 3():22-6. PubMed ID: 3894125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion.
    Reeves ML; Seigler DE; Ryan EA; Skyler JS
    Am J Med; 1982 Apr; 72(4):673-80. PubMed ID: 7041646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
    Breton MD; Kanapka LG; Beck RW; Ekhlaspour L; Forlenza GP; Cengiz E; Schoelwer M; Ruedy KJ; Jost E; Carria L; Emory E; Hsu LJ; Oliveri M; Kollman CC; Dokken BB; Weinzimer SA; DeBoer MD; Buckingham BA; Cherñavvsky D; Wadwa RP;
    N Engl J Med; 2020 Aug; 383(9):836-845. PubMed ID: 32846062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.
    Saudek CD; Duckworth WC; Giobbie-Hurder A; Henderson WG; Henry RR; Kelley DE; Edelman SV; Zieve FJ; Adler RA; Anderson JW; Anderson RJ; Hamilton BP; Donner TW; Kirkman MS; Morgan NA
    JAMA; 1996 Oct 23-30; 276(16):1322-7. PubMed ID: 8861991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined continuous subcutaneous insulin infusion and multiple subcutaneous injections in type I diabetic patients.
    Schiffrin A; Belmonte M
    Diabetes Care; 1981; 4(6):595-600. PubMed ID: 6751734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal-rate intravenous insulin infusion compared to conventional insulin treatment in patients with type II diabetes. A prospective crossover trial.
    Blackshear PJ; Roussell AM; Cohen AM; Nathan DM
    Diabetes Care; 1989; 12(7):455-63. PubMed ID: 2667926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Threshold-based insulin-pump interruption for reduction of hypoglycemia.
    Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR;
    N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
    Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
    Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metabolic and psychological parameters during continuous subcutaneous insulin infusion and intensified conventional insulin treatment in type I diabetic patients.
    Schottenfeld-Naor Y; Galatzer A; Karp M; Josefsberg Z; Laron Z
    Isr J Med Sci; 1985 Oct; 21(10):822-8. PubMed ID: 3908396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term, ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients.
    Barbosa J; Menth L; Eaton J; Sutherland D; Freier EF; Najarian J
    Diabetes Care; 1981; 4(2):269-74. PubMed ID: 7011745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.
    Quirós C; Patrascioiu I; Giménez M; Vinagre I; Vidal M; Jansà M; Conget I
    Endocrinol Nutr; 2014; 61(6):318-22. PubMed ID: 24533929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
    Heptulla RA; Allen HF; Gross TM; Reiter EO
    Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.